Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting
Open Access
- 11 April 2003
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 73 (1) , 18-25
- https://doi.org/10.1002/ajh.10323
Abstract
Hypereosinophilic syndromes are often associated with thrombosis through unclear mechanisms, and mastocytosis has been associated with a variety of bleeding disorders. The present studies were aimed at defining the roles and interactions of eosinophil and mast cell constituents on the kinetics of blood clotting as measured by thromboelastograms. Eosinophil granule proteins and purified eosinophil peroxidase markedly reduced the anticoagulant properties of the mast cell tryptase/heparin complex. Moreover, eosinophil peroxidase by itself functioned as a powerful procoagulant and also inhibited the anticoagulant actions of heparin in a chromogenic assay for antithrombin III/factor Xa activity. The anticoagulant activity of the tryptase/heparin complex was attributable exclusively to the associated heparin and not to the intrinsic enzymatic activity of tryptase. Eosinophil granule proteins also strongly inhibited the enzymatic activity of tryptase in the presence of hydrogen peroxide, thus implicating a critical role for eosinophil peroxidase. We conclude that eosinophil granule proteins and eosinophil peroxidase both function as powerful procoagulants and also inhibit the anticoagulant and enzymatic activities of mast cell tryptase. The present results thus provide a mechanistic rationale for the well-established link between certain eosinophilic inflammatory disorders and hypercoagulant states. They also suggest that eosinophils may play an important role in neutralizing the anticoagulant activity of mast cell tryptase/heparin in various diseases. Am. J. Hematol. 73:18–25, 2003.Keywords
This publication has 33 references indexed in Scilit:
- Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer.Published by Elsevier ,2021
- Neutrophil Myeloperoxidase Is a Potent and Selective Inhibitor of Mast Cell TryptaseArchives of Biochemistry and Biophysics, 1999
- Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesionsInternational Journal of Cancer, 1997
- Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomySurgical Endoscopy, 1995
- [6] Tryptase: A mast cell serine proteasePublished by Elsevier ,1994
- High susceptibility to ADP-induced thrombus formation in mast cell-deficient v miceThrombosis Research, 1985
- The cardiovascular manifestations of the hypereosinophilic syndromeThe American Journal of Medicine, 1979
- Enhancement of factor XII dependent reactions by eosinophil cationic proteinThrombosis Research, 1979
- Evaluation of three methods used to identify accelerated coagulabilityThrombosis Research, 1977
- The identification of accelerated coagulabilityThrombosis Research, 1976